BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9274528)

  • 1. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease.
    Ogden GR; Chisholm DM; Morris AM; Stevenson JH
    J Pathol; 1997 Jun; 182(2):180-4. PubMed ID: 9274528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
    Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
    Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
    J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
    Ogden GR; Kiddie RA; Lunny DP; Lane DP
    J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
    Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
    Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 expression in oral cancer: observations of a South Indian study.
    Pillay M; Vasudevan DM; Rao CP; Vidya M
    J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
    Bathi RJ; Prabhat
    Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
    Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Zhang Q
    Ai Zheng; 2003 Jan; 22(1):77-82. PubMed ID: 12561442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 overexpression in oral mucosa in relation to smoking.
    van Oijen MG; van de Craats JG; Slootweg PJ
    J Pathol; 1999 Mar; 187(4):469-74. PubMed ID: 10398108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
    Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
    Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
    Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
    J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC.
    Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Serpico R; Rubini C; Fioroni M; Fanali S; Piattelli A
    Anticancer Res; 2000; 20(5A):2891-7. PubMed ID: 11062698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.